Concepedia

Roy Maimon

RM

Statistics

Publications

6

Citations

262

H-Index

6

Active since

2019

Affiliations

Tel Aviv University(Current)

Massachusetts General Hospital

Charles University

University of Auckland

University of California San Diego

Roy Maimon is an author at Tel Aviv University specializing in life sciences, neurodegenerative disorders, and molecular neuroscience.

ORCID

Publications per year

2019–2025

6

Publications

6

Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model

Ariel Ionescu, Tal Gradus, Topaz Altman et al. · Cell Death and Disease · 2019 · 89 citations · Full text

, , +17

CRMP2 mediates Sema3F‐dependent axon pruning and dendritic spine remodeling

Jakub Žiak, Romana Weissová, Kateřina Jeřábková et al. · EMBO Reports · 2020 · 54 citations · Full text

, , +13

Structural Principles in Robo Activation and Auto-inhibition

Reut Barak, Galit Yom-Tov, Julia Guez-Haddad et al. · Cell · 2019 · 50 citations · Full text

, , +6

Aberrant splicing in Huntington’s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification

Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas et al. · Nature Neuroscience · 2025 · 37 citations · Full text

, , +13

A CRMP4‐dependent retrograde axon‐to‐soma death signal in amyotrophic lateral sclerosis

Roy Maimon, Lior Ankol, Tal Gradus Pery et al. · The EMBO Journal · 2021 · 17 citations · Full text

, , +17

1–5 of 6